Prestige Biologics Co., Ltd.
334970
企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
Prestige Biologics Co., Ltd. operates as a CDMO (Contract Development and Manufacturing Organization) that provides integrated process development, analytical testing, and manufacturing services in response to the advancement of the biopharmaceutical industry and the expanding trend of global pharmaceutical companies outsourcing research, development, and manufacturing. The biopharmaceutical industry has recently been rapidly reorganizing around high modality complexity, such as antibody drugs, biosimilars, and cell and gene therapies, and structural limitations on pharmaceutical and biotech companies building and operating their own production facilities are expanding due to increasing process complexity, stricter regulation, and rising investment costs.
代表理事
Lim Yeongsu
成立日期
2015年6月2日
法人类型
韩国创业板
行业分类
Manufacture of medicaments
法人注册号
11011-5739804
营业执照号
777-86-00083
电话号码
043-232-1552
传真号码
043-233-1552
公司地址
197 Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do
产品与服务
评论